Key result
Botulinum toxin may reduce postoperative AF in selected cardiac surgery patients.
Why the study?
Postoperative atrial fibrillation is a common cardiac surgery complication linked to autonomic imbalance, and the therapeutic potential of botulinum toxin to modulate autonomic activity required review.
Does botulinum toxin prevent postoperative atrial fibrillation in patients undergoing cardiac surgery?
Does botulinum toxin prevent postoperative atrial fibrillation in patients undergoing cardiac surgery?
While botulinum toxin is being explored for preventing postoperative atrial fibrillation, the FDA mandates boxed warnings and REMS for all botulinum toxin products due to the serious risk of distant spread causing systemic botulism.
Answers are grounded in this paper and cite their sources.
Should not change practice; leaves open efficacy and safety of botulinum toxin for POAF pending RCTs.
Botulinum toxin, previously used mainly in neurology and aesthetic medicine, is increasingly finding application in new fields, including cardiology. Its ability to selectively and temporarily block cholinergic conduction makes it a promising tool for modulating the activity of the autonomic nervous system, which is important in the prevention of postoperative atrial fibrillation (POAF). Atrial fibrillation is one of the most common postoperative complications in cardiac surgery, significantly affecting the course of recovery and patient prognosis. An imbalance between sympathetic and parasympathetic regulation of the heart rhythm plays a significant role in the pathogenesis of this disorder. This paper reviews the current state of knowledge on the therapeutic potential of botulinum toxin in the prevention of POAF. The data indicate that the use of botulinum toxin may lead to a reduction in the incidence of postoperative arrhythmias in selected patient groups. The need for further research to determine the optimal treatment regimen and identify the patient population most likely to benefit from this type of therapy was also emphasised.
No takes yet. Share an insight, caveat, or question.
Kaźmierska et al. (2025) studied this question. Botulinum toxin may reduce the incidence of postoperative atrial fibrillation in selected patient groups undergoing cardiac surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: